Maravai LifeSciences Holdings, Inc.'s stock has plummeted from $60 to $2.1 per share due to declining COVID vaccine-related revenues, but I am upgrading from a "Sell" to a "Hold" rating. The ...
NEW YORK, NY / ACCESS Newswire / April 6, 2025 / If you suffered a loss on your Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) investment and want to learn about a potential recovery under the ...
MRVI Investors Have Opportunity To Lead Maravai Lifesciences Holdings, Inc. Securities Fraud Lawsuit
Why: Rosen Law Firm, a global investor rights law firm, reminds of purchasers of securities of Maravai Lifesciences Holdings, Inc. (NASDAQ: MRVI ) between August 7, 2024 and February 24 ...
Mitsubishi UFJ Asset Management Co. Ltd. boosted its position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Free Report) by 118.5% in the fourth quarter, HoldingsChannel reports.
Greetings. Welcome to Maravai LifeSciences fourth quarter 2024 results earnings call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal ...
For the year ended December 31, 2024, refers to the adjustment of the Tax Receivable Agreement liability primarily due to changes in Maravai’s estimated state apportionment and the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback